Recent study findings suggest pediatricians widely prescribe melatonin; however, there is no common consent about its use in developing children. The study, published in the European Journal of Pediatric Neurology and led by Oliviero Bruni, MD, and colleagues, sought to understand melatonin prescribing rates in healthy children with chronic insomnia. The researchers conducted a cross-sectional open survey administered to pediatricians. Among 428 respondents, 97.4% reported they prescribe melatonin. Specifically, 87.3% said they use it in children 1-2 years of age, 62.1% in children aged 2–5, and 42.5% in children aged 10–18. The study team also found that 84.9% of pediatricians suggested melatonin use 30 minutes before bedtime, 37.9% indicated continuing treatment for one month, 30.2% for 2–3 months, and 74.1% of pediatricians usually prescribed melatonin 1 mg/day. Overall, roughly all surveyed pediatricians found melatonin effective in reducing difficulties falling asleep; however, the researchers note that there is a need for clear guidelines to help standardize melatonin use in children.
